Serum Institute To Produce Sputnik V From September

New Delhi: Russian Vaccine Sputnik V will be produced in the Indian-based Serum Institute Manufacturing Unit from September. Russian RDIF (Russian Direct Investment Fund) said they “intend to produce more than 300 million doses in India per year”. Technology transfer has begun and the first vaccine batch is expected in September.
“As part of the technical transfer process, SII has received cell samples and vectors from the Gamaleya Center. With their imports approved by the drug controller General India), the cultivation process has begun,” Read statements from RDIF.

“I like to partner with RDIF to produce sputnik vaccines. We hope to make millions of doses in the coming months with a trial batch starting in September,” said Chairman of the Serum Institute of Poonawalla Adar Poonawalla.

“With high efficacy and good security profiles, it is very important that sputnik vaccines can be accessed in full size for people throughout India and the world. Given the uncertainty of the virus, it is important for international institutions, and the government to collaborate and further bind our fight against the fight Pandemic, “he added.

Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said strategic partnerships are “a big step to substantially improve our production capabilities which show perfect examples to join and expertise to save lives both in India and throughout the world.

The announcement came when India tried to increase its vaccination efforts. The target is to examinate all adult populations in December.

Dr. NK Arora, who heads a group of national experts in the vaccine administration, has expressed confidence that the government will be able to meet the December target.

But the lack of vaccines continues in the bag.
Delhi had to close several vaccine centers because the supply of Covishield was up, deputy head of Minister Manish Sisodia said yesterday.

Only 36,310 vaccine doses that can be given in Delhi until 10pm on Monday compared to the previous average of 1.5 lakh doses given a day.